Do you want to read an article? Please log in or register.
Mucus plugging, air trapping, and bronchiectasis are important outcome measures in assessing progressive childhood cystic fibrosis lung disease
Pulmonary Fibrosis
RECOMMENDED
Related content
RECOMMENDED
Pulmonary Fibrosis
Determinants of lung disease progression measured by lung clearance index in children with cystic fibrosis
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Eur Respir J
Stanojevic S, Davis SD, Perrem L, Shaw M, Retsch-Bogart G, Davis M, Jensen R, Clem CC, Isaac SM, Guido J, Jara S, France L, McDonald N, Solomon M, Sweezey N, Grasemann H, Waters V, Sanders DB, Ratjen FA
doi: 10.1183/13993003.03380-2020
Pulmonary FibrosisBronchi
Quantitative assessment of airway dimensions in young children with cystic fibrosis lung disease using chest computed tomography
Pediatr Pulmonol.
Kuo W, Soffers T, Andrinopoulou ER, Rosenow T, Ranganathan S, Turkovic L, Stick SM, Tiddens HAWM; AREST CF
doi: 10.1002/ppul.23787.
Initial acquisition and succession of the cystic fibrosis lung microbiome is associated with disease progression in infants and preschool children
PLoS Pathog.
Muhlebach MS, Zorn BT, Esther CR, Hatch JE, Murray CP, Turkovic L, Ranganathan SC, Boucher RC, Stick SM, Wolfgang MC
doi: 10.1371/
RECOMMENDED
Pulmonary Fibrosis
Targeting Proteases in Cystic Fibrosis Lung Disease: Paradigms, Progress, and Potential
★ 1
Recommended by
Dr Martin Frey, Faculty Member
Am J Respir Crit Care Med.
McKelvey MC, Weldon S, McAuley DF, Mall MA, Taggart CC
doi: 10.1164/rccm.201906-1190PP.
Pulmonary Fibrosis
Respiratory rate in infants with cystic fibrosis throughout the first year of life and association with lung clearance index measured shortly after birth
J Cyst Fibros.
Korten I, Kieninger E, Yammine S, Cangiano G, Nyilas S, Anagnostopoulou P, Singer F, Kuehni CE, Regamey N, Frey U, Casaulta C, Spycher BD, Latzin P; SCILD; BILD study group
doi: 10.1016/j.jcf.2018.07.002.
RECOMMENDED
Pulmonary Fibrosis
Early Markers of Cystic Fibrosis Structural Lung Disease: Follow-Up of the ACFBAL Cohort
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Eur Respir J.
Wijker NE, Vidmar S, Grimwood K, Sly PD, Byrnes CA, Carlin JB, Cooper PJ, Robertson CF, Massie RJ, Kemner van de Corput MPC, Cheney J, Tiddens HAWM, Wainwright CE, Australasian Cystic Fibrosis Bronchoalveolar Lavage (ACFBAL) and Follow-up of the ACFBAL (CF-FAB) study groups
doi: 10.1183/13993003.01694-2019.
Pulmonary Fibrosis
Tracheal diverticula in advanced cystic fibrosis: Prevalence, features, and outcomes after lung transplantation
J Cyst Fibros.
Kapnadak SG, Kicska GA, Ramos KJ, Marshall DA, Carroll TY, Pipavath SN, Mulligan MS, Goss CH, Aitken ML
doi: 10.1016/j.jcf.2017.07.015.
Pulmonary Fibrosis
Early follow-up of lung disease in infants with cystic fibrosis using the raised volume rapid thoracic compression technique and computed tomography during quiet breathing
Pediatr Pulmonol.
Gauthier R, Cabon Y, Giroux-Metges MA, Du Boisbaudry C, Reix P, Le Bourgeois M, Chiron R, Molinari N, Saguintaah M, Amsallem F, Matecki S
doi: 10.1002/ppul.23786.
RECOMMENDED
Bronchi
Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials
Lancet Respir Med.
Haworth CS, Bilton D, Chalmers JD, Davis AM, Froehlich J, Gonda I, Thompson B, Wanner A, O'Donnell AE
doi: 10.1016/S2213-2600(18)30427-2.